Vigabatrin Tablet, Film Coated
Product Images NDC 80005-167

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Vigabatrin (NDC 80005-167). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Carnegie Pharmaceuticals Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure (Figure01)

A cumulative distribution plot showing the percentage reduction in seizure frequency on the y-axis against the percentage of patients on the x-axis. The graph compares the effects of three different dosages of vigabatrin (1g/day, 3g/day, and 6g/day) with placebo, illustrating seizure frequency improvement and worsening among patients.*

FDA Label Image

Figure (Figure02)

A cumulative frequency plot showing percentage reduction in seizure frequency on the vertical axis and percentage change from -100 to 100 on the horizontal axis. Two lines represent placebo and 3g/day vigabatrin (VGB) treatments. The graph indicates improvement, no change, or worsening in seizure frequency with treatment groups compared.*

FDA Label Image

Label (Image01)

Label for Vigabatrin Tablets, USP 500 mg oral film-coated tablets. The label includes the NDC 80005-167-11 and states the product is distributed by Carnegie Pharmaceuticals LLC. It indicates a package size of 100 tablets, storage at 20°-25°C, and contains a barcode and lot/expiration placeholders. The label also notes the tablet contains 500 mg of Vigabatrin, USP.*

FDA Label Image

Carton (Image02)

Packaging label for Vigabatrin Tablets, USP 500 mg, a film-coated oral tablet. The label includes dosage strength, NDC 80005-167-11, and instructions for pharmacists to dispense the Medication Guide. It indicates storage conditions (20°C to 25°C) and child-resistant container requirements. Distributed by Carnegie Pharmaceuticals LLC, USA, with a package count of 100 tablets.*

FDA Label Image

Structure (Structure)

Chemical structure of vigabatrin, showing its molecular layout including an amine group and carboxylic acid group connected by a hydrocarbon chain with a vinyl side group.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.